{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:29:24Z","timestamp":1775604564134,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology, Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jormas.2020.05.001","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T21:50:46Z","timestamp":1589320246000},"page":"740-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Medication-related osteonecrosis of the jaw related to epacadostat and pembrolizumab"],"prefix":"10.1016","volume":"121","author":[{"given":"J.","family":"Decaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Magremanne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jormas.2020.05.001_bib0065","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.oraloncology.2015.08.014","article-title":"Osteonecrosis of the jaw a new complication related to Ipilimumab","volume":"51","author":"Owosho","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jormas.2020.05.001_bib0070","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.jormas.2020.05.001_bib0075","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","article-title":"Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw","volume":"16","author":"Chang","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jormas.2020.05.001_bib0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007764","article-title":"T cell costimulation molecules CD80\/86 inhibit osteoclast differentiation by inducing the IDO\/tryptophan pathway","volume":"6","author":"Bozec","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jormas.2020.05.001_bib0085","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fendo.2019.00236","article-title":"Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System","volume":"10","author":"Ponzetti","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jormas.2020.05.001_bib0090","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1158\/0008-5472.CAN-17-2285","article-title":"Discovery of IDO1 inhibitors: From Bench to Bedside","volume":"77","author":"Prendergast","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.jormas.2020.05.001_bib0095","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/vaccines3030703","article-title":"The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity","volume":"3","author":"Mbongue","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jormas.2020.05.001_bib0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fonc.2018.00423","article-title":"Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers","volume":"8","author":"Komiya","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.jormas.2020.05.001_bib0105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrclinonc.2016.58","article-title":"Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination","volume":"13","author":"Boutros","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jormas.2020.05.001_bib0110","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1902\/jop.2009.090057","article-title":"Inhibitory signals mediated by programmed death-1 are involved with T-cell function in chronic periodontitis","volume":"80","author":"Figueira","year":"2009","journal-title":"J Periodontol"},{"key":"10.1016\/j.jormas.2020.05.001_bib0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.currproblcancer.2016.12.001","article-title":"Cutaneous adverse effects of the immune checkpoint inhibitors","volume":"41","author":"Collins","year":"2017","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.jormas.2020.05.001_bib0120","first-page":"1","article-title":"Oral health in oncology: impact of immunotherapy","volume":"23","author":"Jackson","year":"2015","journal-title":"Support Care Cancer"}],"container-title":["Journal of Stomatology, Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785520300951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468785520300951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:07:16Z","timestamp":1762855636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468785520300951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2468785520300951"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2020.05.001","relation":{},"ISSN":["2468-7855"],"issn-type":[{"value":"2468-7855","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication-related osteonecrosis of the jaw related to epacadostat and pembrolizumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology, Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2020.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}